经过几十年发展，我国新材料产业在产业规模、技术进步和体系建设等方面取得明显成就，为国民经济和国防建设做出了重大贡献，具备了良好的发展基础。随着新一轮的科技革新，新材料在电子信息、新能源、生物医药等各领域的应用需求与日俱增。未来几年，中国新材料产业将延续过去高速增长的强劲势头，到2022 年产值有望突破9 万亿元，发展前景十分广阔。

化学药产业经过漫长的发展和沉淀，进入较为平稳的调整期，产业规模增速相对放缓。国际上，美国牢牢占据化学药高端创新源头，拥有大量巨型龙头企业，是全球化学药最大的生产地，在国内，华东地区是我国化学药企业主要集聚地。新技术的出现和技术交叉融合为化学药产业创造新的应用市场，加速化学药研发与多元化发展。企业研发意识的增强、专利悬崖的到来、日趋激烈的市场竞争倒逼化学药企业投入创新，推动CRO 行业的发展，同时相对低端的仿制药企业面临转型，行业集中度不断提升。

Breast cancer liquid biopsy is a cancer diagnostics test executed to understand molecular aspects of breast cancer across healthcare and research settings, such as hospitals, physicians, and pathological and research laboratories. It is a non-invasive blood test that provides researchers, physicians, and surgeons with information about cancer profile of a patient and appropriate therapy to improve survival rate of such patients. The report provides market dynamics and trends related to the global breast cancer liquid biopsy market. The study estimates revenue generated from sales of breast cancer liquid biopsy products and services. The valuations comprise revenue generated from reagents, instruments, and services.

Gene therapy cell culture media is a substance composed of various nutrients that are essential for the growth, maintenance, development, proliferation, and storage of cells. A culture media contains constituents such as glucose, attachment & growth factors, and other important elements that supplement cellular growth. In this report, the global gene therapy cell culture media market is analyzed using the revenue generated by sales of culture media involved in life science and biotechnology research. However, the report does not consider revenue generated by sales of reagents, sera, disposables, consumables, and instruments involved in life sciences and healthcare research.

On January 8, 2020, the pathogen of severe unexplained viral pneumonia was identified. This was sequenced to be the new coronavirus 2019 (2019-nCoV). On February 12, 2020, the International Committee on Taxonomy of Viruses named it 2019-nCoV, which was officially named SARS-CoV-2. The World Health Organization (WHO) eventually declared the disease caused by SARS-CoV-2 coronavirus disease in 2019 (COVID-19). This virus has affected more than 100 million people and killed millions, causing difficulty breathing.

Hormone replacement therapy (HRT) is a treatment used to relieve symptoms of menopause, hypothyroidism, male hypogonadism, and growth hormone deficiency. HRT replaces hormones such as estrogen hormone, human growth hormone, thyroid hormone, testosterone hormone, and progestogen hormone that are at a lower level in the body. For the purpose of analysis, the report segments the global hormone replacement therapy based on therapy type, route of administration, indication, and region. The study covers the information about various therapies used in HRT, which include estrogen hormone replacement therapy, human growth hormone replacement therapy, thyroid hormone replacement therapy, testosterone hormone replacement therapy, and progestogen hormone replacement therapy for the treatment of menopause, hypothyroidism, male hypogonadism, growth hormone deficiency, and other diseases.

Blood purification involves removal of blood from a patient’s body with the help of tubing, extracorporeal cleaning using a device and returning it to the patient’s blood circulation system. For the purpose of analysis, the report segments the global market based on product type, indication, end user, and region. The report provides information about the various types of blood purification devices and consumables used during blood purification treatment. In addition, it provides details about the use of blood purification equipment in various indication such as sepsis, renal diseases, and other diseases such as hepatic failures, drug intoxication, acute pancreatitis, and infectious diseases among others. It further outlines the particulars about the major end users of blood purification equipment, including hospitals and clinics, dialysis centers and other end users such as ambulatory surgical centers, homecare, universities and research institutes. Moreover, it stipulates revenue generated through the sale of blood purification equipment across North America, Europe, Asia-Pacific, and LAMEA.

The global AI in healthcare market is highly fragmented in nature. The market comprises various emerging and established companies, such as General Electric Company, Medtronic plc, and Allscripts Healthcare Solutions, Inc. Moreover, the global companies hold 40.56% cumulatively in the global AI in healthcare market. The emerging companies vary significantly in their product offerings. The following table represents the emerging companies across various AI-enabled healthcare applications.

Genomic data analysis is a computational process that helps researchers and clinicians to analyze and interpret data generated by modern genomics technologies, such as NGS and PCR. The genomic data analysis steps typically include data collection, quality check, data cleaning, processing, modeling, visualization, and reporting, through which the data can be further translated to potential insights. As sequencing technologies are producing millions of high-quality reads per run, the adoption of robust genomic data analysis software solutions has increased significantly over the past few years.

E-health is a relatively recent healthcare practice supported by electronic processes and communication. The report provides market dynamics and trends related to the e-health market. In addition, it presents estimations and forecast of the market. The study estimates revenue generated from the sale of e-health platform that are used in different various domain of the healthcare sector process. Revenue generated from e-health solution such as electronic health records (HER); vendor neutral archive, picture archiving, & communications system (PACS & VNA); laboratory information systems (LIS); telehealth; prescribing solutions; personal health record (PHR) & patient portals; medical apps & clinical decision support systems (CDSS); pharmacy information system; and others have been considered during market estimation. End users such as healthcare providers, payers, healthcare consumers, and others have been considered during market estimation.

The global AI in healthcare market is estimated to grow at a CAGR of 49.8% from 2020 - 2027. Key factors that are driving growth of the market are rising application of artificial intelligence (AI) in healthcare, growing investment in ai healthcare startups and increasing cross-industry partnerships and collaborations are anticipated to drive the market. However, the dearth of skilled ai workforce and imprecise regulatory guidelines for medical software is hampering the growth of the market.

The report provides market dynamics and trends related to the clinical trial imaging services market. Furthermore, it includes the study of revenue generated from the sales of various types of clinical trial imaging service such as divided into clinical trial design and consultation services, reading & analytical services, operational imaging services, project and data management services, and others. Moreover, the report presents this revenue under the segment service type, which provides an idea about the various services offered by the players operating in the clinical trial imaging services market.

双抗已有24亿美元重磅品种，近年将迎来上市爆发期。 双抗是通过化学偶联、重组 DNA 或细胞融合的方式，将不同重链和轻组从而产 生能够同时特异性结合两个不抗原的人工体。 目前上市的 3款双抗中， Rocheoche oche研发的 研发的 Hemlibra在 2020年实现了 24亿美元收入，成为重磅品种。 218 款在研药物中，大部分双抗产品仍然处于 I期临床试验，伴随研发逐 步推进，未来 3-5年将有望迎来双抗药物上市井喷。